Rchr
J-GLOBAL ID：201801005786343216
Update date: Sep. 11, 2024
Okamoto Toru
オカモト トオル | Okamoto Toru
Affiliation and department：
Other affiliations (1)：
-
Osaka University
Institute for Advanced Co-Creation Studies
Professor
Research field (1)：
Virology
Research theme for competitive and other funds (6)：
Papers (189)：
-
Yumi Itoh, Yoichi Miyamoto, Makoto Tokunaga, Tatsuya Suzuki, Akira Takada, Akinori Ninomiya, Tomomi Hishinuma, Mami Matsuda, Yoshihiro Yoneda, Masahiro Oka, et al. Importin-7-dependent nuclear translocation of the Flavivirus core protein is required for infectious virus production. PLoS pathogens. 2024. 20. 8. e1012409
-
Junki Hirano, Tsuyoshi Hayashi, Kouichi Kitamura, Yorihiro Nishimura, Hiroyuki Shimizu, Toru Okamoto, Kazuma Okada, Kentaro Uemura, Ming Te Yeh, Chikako Ono, et al. Enterovirus 3A protein disrupts endoplasmic reticulum homeostasis through interaction with GBF1. Journal of virology. 2024. e0081324
-
Shohei Minami, Tomohiro Kotaki, Yusuke Sakai, Shinya Okamura, Shiho Torii, Chikako Ono, Daisuke Motooka, Rina Hamajima, Ryotaro Nouda, Jeffery A Nurdin, et al. Vero cell-adapted SARS-CoV-2 strain shows increased viral growth through furin-mediated efficient spike cleavage. Microbiology spectrum. 2024. e0285923
-
Junya Okabe, Takahiro Kodama, Yu Sato, Satoshi Shigeno, Takayuki Matsumae, Kazuma Daiku, Katsuhiko Sato, Teppei Yoshioka, Minoru Shigekawa, Masaya Higashiguchi, et al. Regnase-1 downregulation promotes pancreatic cancer through myeloid-derived suppressor cell-mediated evasion of anticancer immunity. Journal of experimental & clinical cancer research : CR. 2023. 42. 1. 262-262
-
Emiko Urano, Yumi Itoh, Tatsuya Suzuki, Takanori Sasaki, Jun-Ichi Kishikawa, Kanako Akamatsu, Yusuke Higuchi, Yusuke Sakai, Tomotaka Okamura, Shuya Mitoma, et al. An inhaled ACE2 decoy confers protection against SARS-CoV-2 infection in preclinical models. Science translational medicine. 2023. 15. 711. eadi2623
ｍore...
MISC (12)：
-
佐藤 悠, 小玉 尚宏, 岡本 徹, 西尾 啓, 山田 涼子, 疋田 隼人, 阪森 亮太郎, 巽 智秀, 竹原 徹郎. Regnase-1を介した肝内胆管癌発症機構の解明. 肝臓. 2022. 63. Suppl.1. A319-A319
-
佐藤 悠, 小玉 尚宏, 岡本 徹, 西尾 啓, 山田 涼子, 疋田 隼人, 阪森 亮太郎, 巽 智秀, 竹原 徹郎. Regnase-1を介した肝内胆管癌発症機構の解明. 肝臓. 2022. 63. Suppl.1. A319-A319
-
Yumi Itoh, Hajime Enatsu, Akira Takada, Toru Okamoto. Engineered ACE2 receptor has a potential for a new therapy of COVID-19. Folia Pharmacologica Japonica. 2022. 157. 2. 155
-
Virology for hepatitis C. 2017. 262. 14. 1363-1368
-
Yohei Mano, Sachiyo Yoshio, Hirotaka Shoji, Masaya Sugiyama, Hiroyoshi Doi, Toru Okamoto, Yosuke Osawa, Kiminori Kimura, Tomoharu Yoshizumi, Ken Shirabe, et al. Critical roles of bone morphogenetic protein 4 in cirrhotic and cancer-associated fibroblasts that regulates cellar senescence and cancer-supportive phenotype in the human liver. HEPATOLOGY. 2016. 64. 86A-86A
ｍore...
Lectures and oral presentations (3)：
-
ウイルスによる宿主への感染戦略
(宮崎大学医学獣医学総合研究科 大学院特別セミナー 2021)
-
ウイルス感染における細胞死の制御
(第 93 回日本生化学会大会 2020)
-
ウイルスによる宿主への感染戦略
(公益財団法人 川崎市産業振興財団 第28回 Tonomachi cafe 2020)
Return to Previous Page
